DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest

Core Insights - DarioHealth Corp. has initiated a strategic review to maximize shareholder value following multiple unsolicited inquiries from interested parties [1][4] - The company has engaged Perella Weinberg Partners as a financial advisor to explore various strategic opportunities, including potential sale or merger [2][4] - Dario recently completed a $17.5 million private placement, enhancing its financial position and providing substantial runway for growth initiatives [1][7] Company Developments - The Board of Directors has formed a Special Committee of independent directors to oversee the strategic review process [2][4] - Dario has optimized its capital structure by converting preferred shares into common shares, creating a clearer equity structure [7] - The company’s pro forma cash position is approximately $40 million as of the end of Q2 2025, positioning it well for future opportunities [7] Market Position - DarioHealth is recognized as a leader in digital health solutions for chronic condition management, offering a comprehensive multi-condition platform supported by clinical evidence [5][6] - The company’s user-centric approach aims to provide continuous and customized care, enhancing user satisfaction and retention [6][7] - Dario's solutions are delivered globally to various stakeholders, including health plans, self-insured employers, and consumers [7]